other

Updated:

MedHelp's peer channel Patient-to-Patient Communities

MedHelp's Patient-to-Patient Communities originated as a feature of MedHelp.org, a consumer health website founded in 1994.

MedHelp's peer channel Patient-to-Patient Communities

MedHelp's Patient-to-Patient Communities originated as a feature of MedHelp.org, a consumer health website founded in 1994. The channel was later carved out as a distinct product offering, targeting healthcare organizations and life sciences companies that want direct access to patient peer-support conversations. The firm maintains offices in New York, Princeton, and Minneapolis. The strategy revolves around hosting unmediated discussion threads for patients with shared diagnoses — diabetes, cancer, mental health, autoimmune disorders. The asset-class mix includes advertising revenue, data licensing, and sponsored program partnerships with pharmaceutical firms. Geographic footprint is primarily North America, with some outreach to English-speaking global users. Deployment data and team size are not publicly available. No recent operational events have been disclosed. The platform operates as a standalone business line, possibly under larger ownership or as a private venture, but the corporate structure remains opaque. A structural differentiator is the raw, user-generated nature of the content — MedHelp does not moderate heavily for medical accuracy, which creates engagement but also regulatory risk. This laissez-faire posture distinguishes it from clinical patient portals and formal patient-support programs run by hospital systems.

General information

Firm type

other

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Additional offices

Princeton, NJ, United States · Minneapolis, MN, United States

Sector focus

Digital HealthHealthcare Services

Frequently asked questions

What is MedHelp's Patient-to-Patient Communities?

It is a network of condition-specific online forums where patients share experiences and advice. Originally a feature of MedHelp.org, the channel now serves healthcare organizations and life sciences companies seeking access to patient conversations.

How does the channel generate revenue?

Revenue comes from advertising displayed on forum pages, data licensing to third-party researchers, and sponsored programs from pharmaceutical partners. The freemium model keeps user growth high while monetizing via B2B relationships.

Who owns or operates MedHelp's Patient-to-Patient Communities?

Ownership structure is not publicly disclosed. The channel appears to be a business unit or spinout from MedHelp.org, which has changed ownership multiple times since its 1994 founding.

What conditions does the platform cover?

The platform hosts forums for dozens of chronic conditions, including diabetes, cancer, heart disease, mental health disorders, autoimmune diseases, and rare genetic conditions. Users self-select into the relevant community.

How does MedHelp moderate medical misinformation?

MedHelp does not heavily moderate forum content for medical accuracy, relying instead on community reporting and basic content filters. This approach risks misinformation but maximizes organic engagement.

What geographic regions does the platform serve?

The user base is primarily North American, with English-language forums accessible globally. Offices in New York, Princeton, and Minneapolis support domestic operations.

Is MedHelp's Patient-to-Patient Communities a charity or a for-profit business?

It operates as a for-profit entity, monetizing user traffic through advertising and data licensing. No philanthropic or non-profit structure has been disclosed.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo